The news is directly about Exelixis and its stock rating by Stifel. The 'Hold' rating suggests that the analyst does not expect significant price movement in the short term. The maintained price target of $23 also indicates that the analyst's valuation of the company has not changed. Therefore, the short term impact on the stock price is expected to be neutral.